Article Details
Retrieved on: 2020-12-21 16:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Thomas Campbell, MD, who directs clinical trials on campus for COVID-19 treatments, including Remdesivir and the Regeneron monoclonal antibodies ...
Article found on: news.cuanschutz.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here